Research study Program year 2023 Source: CMS Open Payments

Multi-Analyte Studies

Research payments

$1,220,166

481 payments

Through program year 2023, $1,220,166 in research payments was reported against Multi-Analyte Studies, across 481 payments, paid by Abbott Laboratories.

Paid by: Abbott Laboratories
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$954,258	381
2022	Research	$265,908	100

Breakdown

Who paid Research payments · program years 2022–2023

Abbott Laboratories $1,220,166 481 payments

Who received the money Research payments · program years 2022–2023

Sansum Diabetes Research Institute Organisation paid for research $416,766 169 payments
Ocean Wellness Center Organisation paid for research $173,748 33 payments
Diabetes And Glandular Disease Clinic, Pc Organisation paid for research $164,204 47 payments
Eastside Research Associates, LLC Organisation paid for research $139,248 52 payments
Rainier Clinical Research Center Organisation paid for research $89,930 49 payments
Iowa Diabetes Research Organisation paid for research $88,375 46 payments
Rocky Mountain Clinical Research, Llc Organisation paid for research $81,557 35 payments
Atlanta Diabetes Associates Organisation paid for research $29,059 19 payments
Remington-Davis INC Organisation paid for research $19,610 10 payments
Texas Diabetes & Endocrinology (TDE) Organisation paid for research $17,669 21 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.